Jeffrey W. Albers
2015
In 2015, Jeffrey W. Albers earned a total compensation of $1.3M as President and Chief Executive Officer at Blueprint Medicines, a 44% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $210,375 |
|---|---|
| Option Awards | $698,776 |
| Salary | $416,667 |
| Total | $1,325,818 |
Albers received $698.8K in option awards, accounting for 53% of the total pay in 2015.
Albers also received $210.4K in non-equity incentive plan and $416.7K in salary.
Rankings
In 2015, Jeffrey W. Albers' compensation ranked 6,569th out of 13,638 executives tracked by ExecPay. In other words, Albers earned more than 51.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,569 out of 13,638 | 52nd |
Division Manufacturing | 2,468 out of 5,190 | 52nd |
Major group Chemicals And Allied Products | 893 out of 1,854 | 52nd |
Industry group Drugs | 716 out of 1,528 | 53rd |
Industry Pharmaceutical Preparations | 557 out of 1,182 | 53rd |
Source: SEC filing on April 28, 2017.
Albers' colleagues
We found three more compensation records of executives who worked with Jeffrey W. Albers at Blueprint Medicines in 2015.